Breast Cancer
The proposed change would delete payable cancer codes if they contain the word "unspecified" even if the word is included in a code that doesn't impact coverage.
Todos Medical Acquires Provista Diagnostics for $7.5M
Through the deal, Todos picks up Provista's Videssa breast cancer test, which is designed to help diagnose the disease following an inconclusive mammogram.
The firm's Q-plasia OncoReader Breast is the first in its line of products for different cancers, including skin, lung, and ovarian cancer.
Roche Elecsys Anti-p53 Test for Cancer Diagnosis Earns CE Mark
The immunoassay can be used to monitor cancer cell remnants in a patient's body and help determine which patients need less invasive treatment.
The company plans to transition its DetermaIO test from research to clinical use and to launch a new research product for immunotherapy monitoring by the end of this year.